125 related articles for article (PubMed ID: 2517443)
1. Unusual occurrence of six anti-erythrocyte alloantibodies in an Rh(D)-negative man with myelodysplastic syndrome.
Wakui H; Tada I; Kimura Y; Yoshida K; Endo Y; Miura AB
Jpn J Med; 1989; 28(6):736-9. PubMed ID: 2517443
[TBL] [Abstract][Full Text] [Related]
2. Alloimmunization to the D antigen by a patient with weak D type 21.
McGann H; Wenk RE
Immunohematology; 2010; 26(1):27-9. PubMed ID: 20795315
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
4. [A case of acute hemolytic transfusion reaction due to alloantibodies against Diego b, Kidd a and Rh-Hr (E, c), resulting in disseminated intravascular coagulation and renal failure].
Kawai M; Tsugawa Y; Yoshimura A; Tofuku Y; Kuroda M; Takeda R; Mori T
Nihon Naika Gakkai Zasshi; 1985 Jun; 74(6):780-5. PubMed ID: 3930636
[No Abstract] [Full Text] [Related]
5. Fatal delayed hemolytic transfusion reaction due to anti-c + E.
Hillman NM
Transfusion; 1979; 19(5):548-51. PubMed ID: 116399
[TBL] [Abstract][Full Text] [Related]
6. Acute Hemolytic Transfusion Reaction Due to the "Anti-E" Rhesus Antibody in a Patient with Crohn's Disease.
Ahn A; Hwang SH
Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532084
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms responsible for delayed and immediate hemolytic transfusion reactions in a patient with anti-E + Jk(b)+ Di(b) and anti-HLA alloantibodies.
Okamoto T; Hashimoto M; Samejima H; Mori A; Wakabayashi M; Takeda A; Nakamura H; Naruse H; Bouike Y; Araki N
Immunopharmacol Immunotoxicol; 2004; 26(4):645-52. PubMed ID: 15658612
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes.
Lin Y; Saskin A; Wells RA; Lenis M; Mamedov A; Callum J; Buckstein R
Vox Sang; 2017 Jan; 112(1):79-86. PubMed ID: 28097704
[TBL] [Abstract][Full Text] [Related]
9. [A D-positive patient carrying anti-D].
Habibi B; Robert N; Le Pennec PY
Rev Fr Transfus Immunohematol; 1982 Oct; 25(5):577-9. PubMed ID: 6819629
[No Abstract] [Full Text] [Related]
10. Delayed hemolytic transfusion reaction caused by anti-LebH antibody.
Weir AB; Woods LL; Chesney C; Neitzer G
Vox Sang; 1987; 53(2):105-7. PubMed ID: 3120409
[TBL] [Abstract][Full Text] [Related]
11. Intravascular hemolytic transfusion reaction without detectable antibodies: A case report and review of literature.
Harrison CR; Hayes TC; Trow LL; Benedetto AR
Vox Sang; 1986; 51(2):96-101. PubMed ID: 2430366
[TBL] [Abstract][Full Text] [Related]
12. Adverse transfusion reactions in patients with aplastic anaemia or myelodysplastic syndromes.
Moncharmont P; Quittançon E; Barday G; Benamara A;
Vox Sang; 2019 May; 114(4):349-354. PubMed ID: 30818416
[TBL] [Abstract][Full Text] [Related]
13. A delayed hemolytic transfusion reaction (DHTR) with multiple alloantibodies (Anti-E, Jka, Dia, Fyb, and S) induced by E-antigen-negative, crossmatch-compatible blood.
Yamane K; Yagihashi A; Sasaki M; Kuwashima K; Morio A; Watanabe N
Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):531-9. PubMed ID: 9805232
[TBL] [Abstract][Full Text] [Related]
14. Anti-Jka, -C, and -E in a single patient, initially demonstrable only by the manual hexadimethrine bromide (Polybrene) test, with incompatibilities confirmed by 51Cr-labeled red cell studies.
Maynard BA; Smith DS; Farrar RP; Kraetsch RE; Chaplin H
Transfusion; 1988; 28(4):302-6. PubMed ID: 3133842
[TBL] [Abstract][Full Text] [Related]
15. Alloantibodies other than anti-D in pregnant women.
Chow MP; Yung CH; Hu HY; Lyou JY; Hwan MY; Shi YJ
Zhonghua Yi Xue Za Zhi (Taipei); 1989 Mar; 43(3):205-7. PubMed ID: 2507120
[TBL] [Abstract][Full Text] [Related]
16. Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome.
Singhal D; Kutyna MM; Chhetri R; Wee LYA; Hague S; Nath L; Nath SV; Sinha R; Wickham N; Lewis ID; Ross DM; Bardy PG; To LB; Reynolds J; Wood EM; Roxby DJ; Hiwase DK
Haematologica; 2017 Dec; 102(12):2021-2029. PubMed ID: 28983058
[TBL] [Abstract][Full Text] [Related]
17. Hemolytic disease of the newborn due to anti-C and anti-G masquerading as anti-D.
Yesus YW; Akhter JE
Am J Clin Pathol; 1985 Dec; 84(6):769-72. PubMed ID: 3934960
[TBL] [Abstract][Full Text] [Related]
18. Long-term in vivo survival of Rh(D)-negative donor red cells in a patient with anti-LW.
Chaplin H; Hunter VL; Rosche ME; Shirey RS
Transfusion; 1985; 25(1):39-43. PubMed ID: 3918363
[TBL] [Abstract][Full Text] [Related]
19. Increased Incidence of Red Blood Cell Alloantibodies in Myelodysplastic Syndrome.
Rozovski U; Ben-Tal O; Kirgner I; Mittelman M; Hareuveni M
Isr Med Assoc J; 2015 Oct; 17(10):624-7. PubMed ID: 26665317
[TBL] [Abstract][Full Text] [Related]
20. Anti-Rho(D) in two Rh-positive patients receiving kidney grafts from an Rh-immunized donor.
Ramsey G; Israel L; Lindsay GD; Mayer TK; Nusbacher J
Transplantation; 1986 Jan; 41(1):67-9. PubMed ID: 3001981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
